By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Purpose Finding appropriate in-vitro modeling to predict in-vivo performance of oral dosage forms has always been challenging for pharmaceutical industries. In recent years there has been a push to improve biorelevance of in-vitro testing in an attempt to model complex in-vivo processes such as supersaturation and precipitation.
